賽賓公司再獲三家機構評級買入

EQS 新聞 via SEAPRWire.com / 2022-08-12 / 05:09 EST/EDT 賽賓公司再獲三家機構評級買入   來自加拿大多倫多的迷幻藥療法公司賽賓公司(NEO:CYBN)(NYSE American:CYBN)(Cybin),剛獲三家機構買入評級,目標價為6至10美元,此前,已有7家機構…

拜登計劃兩年內將迷幻藥療法合法化

EQS 新聞 via SEAPRWire.com / 2022-08-01 / 05:21 EST/EDT 拜登計劃兩年內將迷幻藥療法合法化   經過十多年被誤解後,迷幻藥療法終於在醫學上取得認可,美國衛生和公共服務部的信件披露了美國食品和藥物管理局預計批准的MDMA和psilocybin治療方法。   隨著精神健康和…

亞博科技贏得中國七省體育彩票終端機招標

EQS 新聞 via SEAPRWire.com / 2022-07-28 / 16:21 UTC+8     亞博科技贏得中國七省體育彩票終端機招標     (香港,2022年7月28日)- 亞博科技控股有限公司(「亞博科技」,香港聯交所股份代號: 8279)欣然宣佈,其全資子公司北京亞博高騰科技有限公司(「亞博高騰…

EQS-News: CICC Initiates Sirnaomics (2257.HK) at Outperform Rating with Target Price of HKD106.00

EQS-News / 04/07/2022 / 17:56 UTC+8 CICC Initiates Sirnaomics (2257.HK) at Outperform Rating with Target Price of HKD106.00   China International Capital Corporation (CICC) initiates coverage of Sirnaomics at “Outperform” rating, with a target price of HKD106.00. CICC said, Sirnaomics is an RNA therapeutics pioneer in China. RNA therapeutics is a rapidly growing field with potential […]

EQS-News: 51Talk releases first quarter results, announcing spin-off with listed company targeting overseas market

EQS-News / 04/07/2022 / 11:20 UTC+8 51Talk releases first quarter results, announcing spin-off with listed company targeting overseas market On 24 June 2022, 51Talk(COE.US) announced its first quarter 2022 financial results. The report indicates 51Talk has restructured its mainland and overseas business and completed operational restructuring. By spinning off its mainland business from the listed company, […]